Objective Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder leading to paralysis and subsequent death in young children. Initially considered a motor neuron disease, extra‐neuronal involvement is increasingly recognized. The primary goal of this study was to investigate alterations in lipid metabolism in SMA patients and mouse models of the disease. Methods We analyzed clinical data collected from a large cohort of pediatric SMA type I–III patients as well as SMA type I liver necropsy data. In parallel, we performed histology, lipid analysis, and transcript profiling in mouse models of SMA. Results We identify an increased susceptibility to developing dyslipidemia in a cohort of 72 SMA patients and liver steatosis in pathological samples. Similarly, fatty acid metabolic abnormalities were present in all SMA mouse models studied. Specifically, Smn2B/‐ mice displayed elevated hepatic triglycerides and dyslipidemia, resembling non‐alcoholic fatty liver disease (NAFLD). Interestingly, this phenotype appeared prior to denervation. Interpretation This work highlights metabolic abnormalities as an important feature of SMA, suggesting implementation of nutritional and screening guidelines in patients, as such defects are likely to increase metabolic distress and cardiovascular risk. This study emphasizes the need for a systemic therapeutic approach to ensure maximal benefits for all SMA patients throughout their life.

Abnormal fatty acid metabolism is a core component of spinal muscular atrophy / M. Deguise, G. Baranello, C. Mastella, A. Beauvais, J. Michaud, A. Leone, R. De Amicis, A. Battezzati, C. Dunham, K. Selby, J. Warman Chardon, H.J. McMillan, Y. Huang, N.L. Courtney, A.J. Mole, S. Kubinski, P. Claus, L.M. Murray, M. Bowerman, T.H. Gillingwater, S. Bertoli, S.H. Parson, R. Kothary. - In: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. - ISSN 2328-9503. - 6:8(2019 Aug), pp. 1519-1532.

Abnormal fatty acid metabolism is a core component of spinal muscular atrophy

A. Leone;R. De Amicis;A. Battezzati;S. Bertoli;
2019

Abstract

Objective Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder leading to paralysis and subsequent death in young children. Initially considered a motor neuron disease, extra‐neuronal involvement is increasingly recognized. The primary goal of this study was to investigate alterations in lipid metabolism in SMA patients and mouse models of the disease. Methods We analyzed clinical data collected from a large cohort of pediatric SMA type I–III patients as well as SMA type I liver necropsy data. In parallel, we performed histology, lipid analysis, and transcript profiling in mouse models of SMA. Results We identify an increased susceptibility to developing dyslipidemia in a cohort of 72 SMA patients and liver steatosis in pathological samples. Similarly, fatty acid metabolic abnormalities were present in all SMA mouse models studied. Specifically, Smn2B/‐ mice displayed elevated hepatic triglycerides and dyslipidemia, resembling non‐alcoholic fatty liver disease (NAFLD). Interestingly, this phenotype appeared prior to denervation. Interpretation This work highlights metabolic abnormalities as an important feature of SMA, suggesting implementation of nutritional and screening guidelines in patients, as such defects are likely to increase metabolic distress and cardiovascular risk. This study emphasizes the need for a systemic therapeutic approach to ensure maximal benefits for all SMA patients throughout their life.
Settore BIO/09 - Fisiologia
Settore MED/49 - Scienze Tecniche Dietetiche Applicate
Centro Internazionale per lo Studio della Composizione Corporea ICANS
Article (author)
File in questo prodotto:
File Dimensione Formato  
Deguise_et_al-2019-Annals_of_Clinical_and_Translational_Neurology.pdf

accesso aperto

Descrizione: online first
Tipologia: Publisher's version/PDF
Dimensione 8.24 MB
Formato Adobe PDF
8.24 MB Adobe PDF Visualizza/Apri
Deguise_et_al-2019-Annals_of_Clinical_and_Translational_Neurology.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 8.24 MB
Formato Adobe PDF
8.24 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/667224
Citazioni
  • ???jsp.display-item.citation.pmc??? 32
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 50
social impact